KR960008666B1 - Novel retinoid - Google Patents

Novel retinoid Download PDF

Info

Publication number
KR960008666B1
KR960008666B1 KR91004702A KR910004702A KR960008666B1 KR 960008666 B1 KR960008666 B1 KR 960008666B1 KR 91004702 A KR91004702 A KR 91004702A KR 910004702 A KR910004702 A KR 910004702A KR 960008666 B1 KR960008666 B1 KR 960008666B1
Authority
KR
South Korea
Prior art keywords
signifies
novel retinoid
alkyl
retinoid
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR91004702A
Other languages
English (en)
Korean (ko)
Other versions
KR910016674A (ko
Inventor
Guenter Gross
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of KR910016674A publication Critical patent/KR910016674A/ko
Application granted granted Critical
Publication of KR960008666B1 publication Critical patent/KR960008666B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/12—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Vapour Deposition (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
KR91004702A 1990-03-27 1991-03-25 Novel retinoid Expired - Fee Related KR960008666B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH1008/90 1990-03-27
CH100890 1990-03-27

Publications (2)

Publication Number Publication Date
KR910016674A KR910016674A (ko) 1991-11-05
KR960008666B1 true KR960008666B1 (en) 1996-06-28

Family

ID=4200298

Family Applications (1)

Application Number Title Priority Date Filing Date
KR91004702A Expired - Fee Related KR960008666B1 (en) 1990-03-27 1991-03-25 Novel retinoid

Country Status (23)

Country Link
US (1) US5158773A (enExample)
EP (1) EP0449099B1 (enExample)
JP (1) JPH0798797B2 (enExample)
KR (1) KR960008666B1 (enExample)
AT (1) ATE130848T1 (enExample)
AU (1) AU646439B2 (enExample)
CA (1) CA2037150C (enExample)
DE (1) DE59106962D1 (enExample)
DK (1) DK0449099T3 (enExample)
ES (1) ES2080848T3 (enExample)
FI (1) FI96201C (enExample)
GR (1) GR3019014T3 (enExample)
HR (1) HRP930344B1 (enExample)
HU (1) HU207980B (enExample)
IE (1) IE71178B1 (enExample)
IL (1) IL97607A (enExample)
MC (1) MC2222A1 (enExample)
NO (1) NO174801B (enExample)
NZ (1) NZ237513A (enExample)
PT (1) PT97148B (enExample)
SA (1) SA91110302B1 (enExample)
YU (1) YU48480B (enExample)
ZA (1) ZA912075B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5710176A (en) * 1994-09-16 1998-01-20 Bar-Ilan University Retinoyloxy (substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
US6040342A (en) * 1994-09-16 2000-03-21 Bar-Ilan University Retinoyloxy (alkyl-substituted) methyl butyrates useful for the treatment of cancer and other proliferative diseases
US5534261A (en) * 1995-01-17 1996-07-09 University Of Southern California Retinoid-based compositions and method for preventing adhesion formation using the same
WO1998000127A1 (en) * 1996-07-02 1998-01-08 Bar-Ilan University Retinoyloxy(substituted)alkylene butyrates useful for the treatment of cancer and other proliferative diseases
US6130248A (en) * 1996-12-30 2000-10-10 Bar-Ilan University Tricarboxylic acid-containing oxyalkyl esters and uses thereof
US6043389A (en) * 1997-03-11 2000-03-28 Mor Research Applications, Ltd. Hydroxy and ether-containing oxyalkylene esters and uses thereof
US6124495A (en) * 1997-03-11 2000-09-26 Beacon Laboratories, Inc. Unsaturated oxyalkylene esters and uses thereof
US6110970A (en) * 1997-03-11 2000-08-29 Beacon Laboratories, Inc. Nitrogen-containing oxyalkylene esters and uses thereof
US5939455A (en) * 1997-03-11 1999-08-17 Beacon Laboratories, Inc. Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives
US6110955A (en) * 1997-03-11 2000-08-29 Beacon Laboratories, Inc. Metabolically stabilized oxyalkylene esters and uses thereof
US6030961A (en) * 1997-03-11 2000-02-29 Bar-Ilan Research & Development Co., Ltd. Oxyalkylene phosphate compounds and uses thereof
US6720445B2 (en) * 2000-12-21 2004-04-13 Beacon Laboratories, Inc. Acetyloxymethyl esters and methods for using the same
MX390018B (es) 2015-10-30 2025-03-20 Leo Pharma As Formulaciones de isotretinoina y usos y metodos de las mismas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476056A (en) * 1982-11-05 1984-10-09 Hoffmann-La Roche Inc. Trifluoromethoxy analogs of aromatic retinoids
US4677120A (en) * 1985-07-31 1987-06-30 Molecular Design International Topical prodrugs for treatment of acne and skin diseases
JP2622955B2 (ja) * 1986-07-29 1997-06-25 エイボン プロダクツ インコ−ポレイテツド 無水化粧品
DK498487A (da) * 1986-10-06 1988-04-07 Hoffmann La Roche Hidtil ukendte retinoider
ZA877325B (en) * 1986-10-06 1988-04-07 F. Hoffmann-La Roche & Co. Aktiengesellschaft Novel retinoids

Also Published As

Publication number Publication date
US5158773A (en) 1992-10-27
ZA912075B (en) 1991-12-24
IE911005A1 (en) 1991-10-09
EP0449099A3 (en) 1993-02-03
EP0449099A2 (de) 1991-10-02
IL97607A (en) 1996-08-04
FI911207L (fi) 1991-09-28
FI96201C (fi) 1996-05-27
AU7383191A (en) 1991-10-03
EP0449099B1 (de) 1995-11-29
YU48480B (sh) 1998-09-18
JPH04221362A (ja) 1992-08-11
FI911207A0 (fi) 1991-03-12
CA2037150C (en) 1999-12-28
PT97148A (pt) 1991-11-29
KR910016674A (ko) 1991-11-05
CA2037150A1 (en) 1991-09-28
NO174801B (no) 1994-04-05
NO174801C (enExample) 1994-07-13
SA91110302B1 (ar) 2001-10-07
HRP930344B1 (en) 1998-12-31
NZ237513A (en) 1993-09-27
HU207980B (en) 1993-07-28
MC2222A1 (fr) 1993-02-02
IE71178B1 (en) 1997-01-29
FI96201B (fi) 1996-02-15
HRP930344A2 (en) 1994-10-31
DK0449099T3 (da) 1996-01-22
ES2080848T3 (es) 1996-02-16
AU646439B2 (en) 1994-02-24
PT97148B (pt) 1998-07-31
HU910968D0 (en) 1991-10-28
HUT57178A (en) 1991-11-28
NO911233L (no) 1991-09-30
YU45591A (sh) 1994-04-05
JPH0798797B2 (ja) 1995-10-25
ATE130848T1 (de) 1995-12-15
IL97607A0 (en) 1992-06-21
DE59106962D1 (de) 1996-01-11
NO911233D0 (no) 1991-03-26
GR3019014T3 (en) 1996-05-31

Similar Documents

Publication Publication Date Title
KR960008666B1 (en) Novel retinoid
GEP20002331B (en) Alkylated Raphamicine Derivatives
EP0350846A3 (en) Condensed heterocyclic compounds and their use in therapy
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
NO871053L (no) Anvendelse av substituerte n-triklormetyltiodikarboksimider i kombinasjon med n,n[-substituerte bis-(2,4-diamino-s-triazin-6-yl)-oligosulfider i vulkaniserbare kautsjukblandinger og slike kautsjukblandinger.
AU529136B2 (en) 1,2,4,5 - tetra-alkyl - 4 arylpiperidines and their use as analgesics and c.n.s. disorders
AU558587B2 (en) Antiinflammatory composition of inositol and piroxicam
ES2008026A6 (es) Procedimiento de preparacion de una solucion acuosa para el tratamiento de los vasos linfaticos superficiales.
AU509744B2 (en) 4-(3-substituted amino)-2-hydroxypropoxy)-5,6,7,8-tetrahydro-1,6,7-naphthalenetriols
EP0206595A3 (en) Thermally stable tryptophanase process for producing the same, and thermally stable tryptophanase-producing microorganism
AU513607B2 (en) 4-amino-benzo(b)bicyclo(33)noners derivatives with anti-depressant properties
FR2387640A1 (enExample)
AU529932B2 (en) 3:,4:-diepi-4:-0-methyl-daunorubicin and derivatives
Crossley et al. A New Trend in the study of the Earlier Period of the Qing Dynasty By American Schloars
IT1236394B (it) Agente anti psoriasi a base di salicilato di papaverina
Collier Syntactic aspects of emotional expression
周广源 THE CHINESE LOAN ELEMENT IN THE ENGLISH LANGUAGE
JPS52111248A (en) Attaching device for twofold door
IT8920000A0 (it) Gruppo di continuita', in particolare per l'alimentazione di emergenza di un personal computer.
GB1526710A (en) 3,4-dihydro-7-hydroxy-8-nitro-2h-pyrrolo(2,1-b)(1,3)thiazin-6(7h)-one and its use as an insecticide
JPS531355A (en) Double effect absorption type refrigerator
JPS53107134A (en) Accordion door hinge
JPS53114247A (en) Sliding-door connecting device
JPS5366342A (en) Arithmetic unit
JPS52156346A (en) Switchboard

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

FPAY Annual fee payment

Payment date: 20080414

Year of fee payment: 13

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20090629

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20090629

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-4-4-P10-P22-nap-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000